Molecular profiling of gingival crevicular fluid fails to distinguish between infrabony and suprabony periodontal defects.

Although the GCF molecular profile clearly differentiates periodontally affected sites from healthy sites, the different architecture between infrabony and suprabony defects is not reflected in GCF biomarker changes.